Treatment of Asthma Exacerbation
Short-acting beta2 agonists (SABAs) like albuterol are the most effective therapy for rapid reversal of airflow obstruction and prompt relief of asthmatic symptoms during an exacerbation, with systemic corticosteroids administered early in the treatment course to address underlying inflammation. 1, 2
Initial Assessment and Management
First-Line Treatment
- Administer albuterol 2.5-5 mg via nebulizer or 4-8 puffs via MDI with spacer, repeating every 20 minutes for 3 doses initially 2
- Albuterol has an onset of action of five minutes or less, peaks within 30-60 minutes, and has a duration of action of 4-6 hours 1
- Puffs can be taken in 10-15 second intervals; longer intervals offer no benefits 1
- Add ipratropium bromide (0.5 mg nebulized or 4-8 puffs by MDI) to albuterol for severe exacerbations 2
Corticosteroid Administration
- Start systemic corticosteroids early as benefits may not be apparent for 6-12 hours 2
- For adults: Prednisone 40-80 mg/day in divided doses until PEF reaches 70% of predicted or personal best 1
- For children: 1-2 mg/kg in 2 divided doses (maximum 60 mg/day) 1
- Oral administration is as effective as intravenous when gastrointestinal absorption is not impaired 1
Oxygen Supplementation
- Administer supplemental oxygen via nasal cannula or mask, targeting oxygen saturation >90% (>95% in pregnant women and patients with heart disease) 2
Monitoring and Reassessment
- Reassess after initial 3 doses of bronchodilator (60-90 minutes after treatment initiation) 2
- Monitor:
- Oxygen saturation continuously
- Respiratory rate and heart rate
- Work of breathing and accessory muscle use
- PEF or FEV1 if possible 2
Severe Exacerbation Management
For severe exacerbations not responding to initial treatment:
- Consider IV magnesium sulfate (2g over 20 minutes) 2
- Nine guidelines support the use of IV magnesium sulfate for severe asthma exacerbations 1
- Arrange immediate transfer to emergency department if:
- No improvement or worsening after initial treatment
- PEF remains <40% of predicted after treatment
- Oxygen saturation <90% despite supplemental oxygen
- Signs of impending respiratory failure 2
Important Considerations
Medication Delivery
- MDI with spacer is as effective as nebulizer treatment when used correctly 3
- For children, use spacer with face mask for those under 4 years 1
Avoid These Common Pitfalls
- Underestimating severity - patients may not appear distressed despite significant airflow obstruction 2
- Oral short-acting beta2 agonists are less potent, take longer to act, and have more side effects compared with inhaled SABAs; their use is strongly discouraged 1
- Antibiotics should be reserved only for cases with clear evidence of bacterial infection (pneumonia, sinusitis) 2
- Sedation is contraindicated in asthma exacerbations 2
Newer Approaches
Recent research shows that a fixed-dose combination of albuterol and budesonide as rescue medication significantly reduced the risk of severe asthma exacerbation by 26% compared to albuterol alone in patients with uncontrolled moderate-to-severe asthma 4. This approach addresses both bronchospasm and inflammation simultaneously.
Discharge Planning
- Ensure patients have been stable on discharge medications for 24 hours 2
- Provide a clear follow-up plan before discharge 2
- For outpatient management after an exacerbation, use prednisone 40-60 mg in single or 2 divided doses for a total of 5-10 days in adults (children: 1-2 mg/kg/day, maximum 60 mg/day for 3-10 days) 1